Leede Financial Has Negative Outlook of QIPT FY2026 Earnings

Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Equities research analysts at Leede Financial reduced their FY2026 earnings per share estimates for shares of Quipt Home Medical in a research report issued on Tuesday, February 11th. Leede Financial analyst D. Loe now anticipates that the company will post earnings per share of ($0.13) for the year, down from their prior estimate of ($0.12). The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.

Quipt Home Medical Price Performance

NASDAQ QIPT traded down $0.27 on Friday, reaching $2.70. 151,349 shares of the stock traded hands, compared to its average volume of 157,914. The firm's fifty day simple moving average is $2.90 and its 200 day simple moving average is $2.82. The company has a quick ratio of 0.86, a current ratio of 1.20 and a debt-to-equity ratio of 0.73. The company has a market cap of $116.34 million, a price-to-earnings ratio of -18.00 and a beta of 0.57. Quipt Home Medical has a 12 month low of $2.30 and a 12 month high of $4.58.

Insider Buying and Selling at Quipt Home Medical

In related news, VP Patrick Dennis Gamble acquired 17,000 shares of the business's stock in a transaction dated Thursday, December 26th. The stock was bought at an average price of $2.45 per share, for a total transaction of $41,650.00. Following the transaction, the vice president now owns 40,057 shares of the company's stock, valued at approximately $98,139.65. The trade was a 73.73 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 13.40% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Quipt Home Medical

A number of institutional investors and hedge funds have recently modified their holdings of QIPT. SG Americas Securities LLC acquired a new stake in shares of Quipt Home Medical during the 3rd quarter valued at $44,000. Royce & Associates LP lifted its position in shares of Quipt Home Medical by 15.8% during the 3rd quarter. Royce & Associates LP now owns 1,768,789 shares of the company's stock valued at $5,165,000 after acquiring an additional 240,980 shares during the last quarter. Verition Fund Management LLC lifted its position in shares of Quipt Home Medical by 207.5% during the 3rd quarter. Verition Fund Management LLC now owns 78,950 shares of the company's stock valued at $231,000 after acquiring an additional 53,275 shares during the last quarter. Atom Investors LP purchased a new stake in shares of Quipt Home Medical in the third quarter valued at $51,000. Finally, State Street Corp lifted its holdings in shares of Quipt Home Medical by 1.0% in the third quarter. State Street Corp now owns 621,388 shares of the company's stock valued at $1,814,000 after purchasing an additional 6,317 shares in the last quarter. Institutional investors and hedge funds own 42.85% of the company's stock.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.